| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Kimberly Gentile | SVP Clinical Operations | 2026-01-05 | 1,956 | $9.93 | $19.42kSell |
| Matthew Buten | Chief Financial Officer | 2026-01-05 | 2,594 | $9.93 | $25.76kSell |
| Bruce Car | Chief Scientific Officer | 2026-01-05 | 2,381 | $9.93 | $23.64kSell |
| George C. Clark | VP Chief Accounting Officer | 2026-01-05 | 1,117 | $9.93 | $11.09kSell |
| Vlad Coric | Chief Executive Officer | 2026-01-05 | 7,430 | $9.93 | $73.78kSell |
| George C. Clark | VP Chief Accounting Officer | 2025-11-17 | 17,000 | $8.52 | $144.77kBuy |
| Gregory Bailey | Director | 2025-11-13 | 400,000 | $7.50 | $3.00MBuy |
| Vlad Coric | Chief Executive Officer | 2025-11-13 | 333,333 | $7.50 | $2.50MBuy |
| Vlad Coric | Chief Executive Officer | 2025-11-13 | 333,333 | $7.50 | $2.50MBuy |
| John W. Childs | Director | 2025-11-13 | 3,333,333 | $7.50 | $25.00MBuy |
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| John W. Childs | 10.30% | 15,564,580 | $197.83M | Insider |
| John Yetimoglu | 4.14% | 6,250,000 | $79.44M | Insider |
| Vlad Coric | 3.70% | 5,590,131 | $71.05M | Insider |
| Gregory Bailey | 1.34% | 2,020,071 | $25.68M | Insider |
| Warren Karl Volles | 0.16% | 248,212 | $3.15M | Insider |
| Matthew Buten | 0.13% | 195,652 | $2.49M | Insider |
| Kimberly Gentile | 0.07% | 99,557 | $1.27M | Insider |
| George C. Clark | 0.06% | 86,978 | $1.11M | Insider |
| Bruce Car | 0.02% | 37,715 | $479.36k | Insider |
| Julia P. Gregory | 0.02% | 25,665 | $326.20k | Insider |